RE:Thoughts on Bio PubThe guy's "wait until the RS to invest" question is flawed to begin with because it presumes the stock price will fall post-consolidation. That won't necesarily happen with Antibe on the upswing. Only companies that do it so they can then finance to keep the lights on should see a drop post-RS. But alas, the psychology accompanying a share consolidation in the mind of the average investor is somthing like, they "lost" some of their shares, so that means they also "lost" value/money when that's clearly not the case. It's a stupid phenomenon but many "investors" are panicky animals.
Also, Dan didn't "struggle" to answer the question. He was trying to gently explain that 1.) the company has been significantly de-risked by the excellent Ph. 2B dose-ranging results, 2.) that retail mis-understood the results (the Ph. 2/3 adaptive language) and 3.) yes, that because of this, they are undervalued.